ArticleJournal of arrhythmia2025

SGLT2 Inhibitor Might Prevent Atrial Fibrillation Related to Metabolic Syndrome via TNF-α Signaling Pathway: A Bioinformatic Study.

Ardian Rizal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.